Eli Lilly
LLY
$763.24
Share price
0.22%
Change (1 day)
-15.72%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Revenue for Eli Lilly (LLY)
Revenue in 2025 (TTM): $49.00 Billion USD
According to Eli Lilly's latest financial reports the company's current revenue (TTM 
) is $49.00 Billion USD. In 2024 the company made a revenue of $45.04 Billion USD an increase over the revenue in the year 2023 that were of $34.12 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eli Lilly from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $49.00 B | 8.79% |
| 2024 | $45.04 B | 32% |
| 2023 | $34.12 B | 19.56% |
| 2022 | $28.54 B | 0.79% |
| 2021 | $28.31 B | 15.4% |
| 2020 | $24.53 B | 9.95% |
| 2019 | $22.31 B | 0.11% |
| 2018 | $22.29 B | -2.52% |
| 2017 | $22.87 B | 7.77% |
| 2016 | $21.22 B | 6.33% |
| 2015 | $19.95 B | 1.75% |
| 2014 | $19.61 B | -15.13% |
| 2013 | $23.11 B | 2.25% |
| 2012 | $22.60 B | -6.93% |
| 2011 | $24.28 B | 5.25% |
| 2010 | $23.07 B | 5.68% |
| 2009 | $21.83 B | 7.15% |
| 2008 | $20.37 B | 9.36% |
| 2007 | $18.63 B | 18.75% |
| 2006 | $15.69 B | 7.14% |
| 2005 | $14.64 B | 5.68% |
| 2004 | $13.85 B | 10.14% |
| 2003 | $12.58 B | 13.59% |
| 2002 | $11.07 B | -4.03% |
| 2001 | $11.54 B | 6.26% |
| 2000 | $10.86 B | 8.59% |
| 1999 | $10.00 B | 15.57% |
| 1998 | $8.65 B | 1.62% |
| 1997 | $8.51 B | 15.94% |
| 1996 | $7.34 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb BMY | $47.63 B | -2.79% | 🇺🇸 USA |
 Merck MRK | $63.92 B | 30.44% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $89.33 B | 82.30% | 🇺🇸 USA |
 Pfizer PFE | $62.46 B | 27.47% | 🇺🇸 USA |
 Sanofi SNY | $47.39 B | -3.28% | 🇫🇷 France |
 GlaxoSmithKline GSK | $40.58 B | -17.18% | 🇬🇧 UK |
 AbbVie ABBV | $57.36 B | 17.07% | 🇺🇸 USA |
 Amgen AMGN | $34.12 B | -30.36% | 🇺🇸 USA |
 Novartis NVS | $53.22 B | 8.61% | 🇨🇭 Switzerland |
 AstraZeneca AZN | $54.98 B | 12.20% | 🇬🇧 UK |